Finally, we could not ignore the essential impact of tumour environment on cell survival and growth and could imagine that IL-6 inhibition through the use of anti-IL-6 antibodies could block cytokine pools secreted by the neighboring cells and thus could reveal a potent benefit in vivo. This evidence concerns the gene IL6 and neoplasm.